Examination of heterogeneity in treatment response to antipsychotic medications

被引：0
|
作者：
Bareis, Natalie [1 ,2 ]
Stroup, T. Scott [1 ,2 ]
机构：
[1] Columbia Univ, Dept Psychiat, Div Behav Hlth Serv & Policy Res, 1051 Riverside Dr, New York, NY 10032 USA
[2] New York State Psychiat Inst & Hosp, 1051 Riverside Dr, New York, NY 10032 USA
来源：
SCHIZOPHRENIA RESEARCH | 2019年 / 211卷
关键词：
SCHIZOPHRENIA TRIAL;
D O I：
10.1016/j.schres.2019.07.033
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：100 / 102
页数：3
相关论文
共 50 条
  • [1] THE HETEROGENEITY OF ANTIPSYCHOTIC RESPONSE IN THE TREATMENT OF SCHIZOPHRENIA
    Stauffer, Virginia L.
    Case, Michael
    Ascher-Svanum, Haya
    Conley, Robert
    Kapur, Shitij
    Kane, John M.
    Kollack-Walker, Sara
    Jacob, Jayanthi
    Kinon, Bruce J.
    SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 502 - 503
  • [2] The Heterogeneity of Antipsychotic Response in the Treatment of Schizophrenia
    Case, Michael G.
    Stauffer, Virginia L.
    Ascher-Svanum, Haya
    Conley, Robert
    Kapur, Shitij
    Kane, John M.
    Kollack-Walker, Sara
    Jacob, Jayanthi
    Kinon, Bruce J.
    BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 76S - 76S
  • [3] The heterogeneity of antipsychotic response in the treatment of schizophrenia
    Case, M.
    Stauffer, V. L.
    Ascher-Svanum, H.
    Conley, R.
    Kapur, S.
    Kane, J. M.
    Kollack-Walker, S.
    Jacob, J.
    Kinon, B. J.
    PSYCHOLOGICAL MEDICINE, 2011, 41 (06) : 1291 - 1300
  • [4] Heterogeneity of Treatment Effects of Long-Acting Injectable Antipsychotic Medications
    Stroup, T. Scott
    Bareis, Natalie A.
    Rosenheck, Robert A.
    Swartz, Marvin S.
    McEvoy, Joseph P.
    JOURNAL OF CLINICAL PSYCHIATRY, 2019, 80 (01)
  • [5] Investigating Heterogeneity in Response to Antipsychotic Treatment in Schizophrenia
    Ahmed, Anthony
    Dodell-Feder, David
    Ilnicki, Andriana
    Marino, Brielle
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S575 - S575
  • [6] Treatment response trajectories and antipsychotic medications: Examination of up to 18 months of treatment in the CATIE chronic schizophrenia trial.
    Levine, Stephen Z.
    Rabinowitz, Jonathan
    Faries, Douglas
    Lawson, Anthony H.
    Ascher-Svanum, Haya
    SCHIZOPHRENIA RESEARCH, 2012, 137 (1-3) : 141 - 146
  • [7] Psychopharmacologic treatment response of HIV-infected patients to antipsychotic medications
    Singh, Dinesh
    Goodkin, Karl
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (04) : 631 - 632
  • [8] Subjective response to atypical antipsychotic medications
    Wirshing, DA
    Marder, SR
    Wirshing, WC
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 302 - 302
  • [9] Personalized treatment with atypical antipsychotic medications
    Edward Kim
    Richard Levy
    Andrei Pikalov
    Advances in Therapy, 2007, 24 : 721 - 740
  • [10] Attributing Hyponatraemia to Treatment with Antipsychotic Medications
    Richard C. Josiassen
    Rita A. Shaughnessy
    Dawn M. Filmyer
    Brett Audino
    Drug Safety, 2011, 34 : 353 - 354
12345